Get started
Author

Mette Ølgod Pedersen

Observed names: M. Pedersen, M.Ø. Pedersen, Mette Pedersen, Mette Ø Pedersen, Mette Ø. Pedersen, Mette ølgod Pedersen, Pedersen, Mette Olgod
Observed institutions: University of Copenhagen, Herlev Hospital, Copenhagen University Hospital, Gentofte Hospital, Rigshospitalet, Zealand University Hospital, Zealand University Hospital Køge
ORCID: 0000-0002-8561-9421
Observed ORCID: 0000-0002-8561-9421
OpenAlex ID: A5084525969
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
2017 · Anupama Reddy, Jenny Zhang, et al. · Cell · 1,097
PDF
MYC translocation partner gene determines survival of patients with large B‐cell lymphoma with MYC ‐ or double‐hit MYC / BCL 2 translocations
2013 · Mette Ø. Pedersen, Anne O. Gang, et al. · European Journal Of Haematology · 122
Double‐hit BCL 2/ MYC translocations in a consecutive cohort of patients with large B‐cell lymphoma – a single centre's experience
2012 · Mette Ø. Pedersen, Anne O. Gang, et al. · European Journal Of Haematology · 99
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group
2011 · A.O. Gang, C. Strøm, et al. · Annals of Oncology · 74
Overexpression of c-myc is associated with adverse clinical features and worse overall survival in multiple myeloma
2016 · Agoston Gyula Szabo, Anne Ortved Gang, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 45
Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP
2018 · Pekka Peroja, Mette Pedersen, et al. · Scientific Reports · 32
PDF
Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers
2017 · Mette Ølgod Pedersen, Anne Ortved Gang, et al. · PLoS ONE · 20
PDF
Cell of origin predicts outcome to treatment with etoposide-containing chemotherapy in young patients with high-risk diffuse large B-cell lymphoma
2014 · Anne O. Gang, Mette Ø. Pedersen, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 14
Stratification by MYC expression has prognostic impact in MYC translocated B‐cell lymphoma—Identifies a subgroup of patients with poor outcome
2019 · Mette Ølgod Pedersen, Anne Ortved Gang, et al. · European Journal Of Haematology · 12
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas
2024 · Maare Arffman, Leo Meriranta, et al. · Med · 11
Frequency and clinical implications of SOX11 expression in Burkitt lymphoma
2016 · Tove Wästerlid, Lena Nordström, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 9
Biomarker‐adapted treatment in high‐risk large B‐cell lymphoma
2025 · Sirpa Leppä, Leo Meriranta, et al. · HemaSphere · 8
PDF
PD‐L1 expression is low in large B‐cell lymphoma with MYC or double‐hit translocation
2019 · Mette Vestergaard Elbæk, Mette Ølgod Pedersen, et al. · Hematological Oncology · 8
PDF
Mutations of ATM Confer a Risk of Inferior Survival in Patients with TP53-wild Type Mantle Cell Lymphoma
2022 · Jean L. Koff, Rachel Kositsky, et al. · Blood · 7
Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma
2019 · Xiang Li, Rachel Kositsky, et al. · Blood · 6
Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice
2024 · Simon Østergaard, Lone Schejbel, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 5
High‐grade B‐cell lymphomas with MYC and BCL2 translocations lack tumor‐associated macrophages and PD‐L1 expression: A possible noninflamed subgroup
2021 · Marie F. Breinholt, Douglas V. N. P. Oliveira, et al. · Hematological Oncology · 5
MYC Translocation Partner Gene Determines Survival in Large B-Cell Lymphoma with MYC- or Double Hit MYC/BCL2 Translocation
2012 · Mette Ølgod Pedersen, Anne Ortved Gang, et al. · Blood · 4
Extramedullary disease in Waldenström macroglobulinemia: A population‐based observational study
2024 · Simon Østergaard, Lars Munksgaard, et al. · eJHaem · 3
PDF
Biomarker-Driven Treatment Strategy in High-Risk Large B-Cell Lymphoma: Final Results of a Nordic Phase 2 Study
2022 · Sirpa Leppa, Judit M. Jørgensen, et al. · Blood · 3
PD-L1 Expression Is Low in Large B-Cell Lymphoma with MYC or Double-Hit Translocation
2018 · Mette Vestergaard Elbæk, Mette Ø Pedersen, et al. · Blood · 3
Core Needle Biopsies in Patients With Lymphoproliferative Malignancies: An Observational Single‐Center Cohort Study
2025 · Blas Holger Mogensen, Torsten Holm Nielsen, et al. · European Journal Of Haematology · 2
PDF
Central nervous system involvement in Waldenström macroglobulinemia: a comparative population-based study of Bing-Neel syndrome and histological transformation
2025 · Simon Østergaard, Lars Munksgaard, et al. · Annals of Hematology · 2
PDF
Prognostic impact of nodal involvement in Waldenström macroglobulinaemia
2024 · Simon Østergaard, Lars Munksgaard, et al. · British Journal of Haematology · 2
PDF
Lack of topoisomerase copy number changes in patients with de novo and relapsed diffuse large B-cell lymphoma
2015 · Mette Ø. Pedersen, Tim S. Poulsen, et al. · Experimental Hematology · 2
Works count: 49
Citation count: 1,625
H-index: 11
I10-index: 11
Year
Topic
Type